Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find Clinical Trials & Studies

Premenopausal Endometriosis Treatment Study

I'm Interested!

A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis

  • Sex at Birth: Female
  • Age: Adult (18 - 64)
  • Accepting Healthy People: No
  • Type: Observational
  • Trial Phase: Phase III
  • Conditions Being Studied:

Study Purpose

The purpose of this research study is to characterize changes in bone mineral density during continuous treatment with the investigational medication for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with moderate-to-severe pain associated with endometriosis.

Who Can Participate

Premenopausal women aged 18 – 50 years, who have a diagnosis of moderate to severe pain associated with endometriosis may be eligible to participate.

Principal Investigator
Angelina Gangestad MD
Department/Division
OBGYN (Fertility and Reproductive Health)

Locations

UH Landerbrook Health Center
5850 Landerbrook Drive
Mayfield Heights OH, 44124

UH Ahuja Medical Center
3999 Richmond Road
Beachwood OH, 44122

  • UH IRB: SITE00002089
  • StudyID: 2023-01319
  • ClinicalTrials.gov: NCT05862272
I'm Interested!

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422